Back to search
FDAFDA · Food and drugs·Recall number Z-2067-2026

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

Published May 13, 2026 · Recall initiated: April 22, 2026

Summary

FDA records medical device Class II recall Z-2067-2026, published May 13, 2026 and initiated April 22, 2026. Recalling firm: BioFire Diagnostics, LLC; Status: Ongoing; Reported quantity: 106 kits (3,180 test); Lot: Lot #s:0883425,0878825/DI: 00815381020192. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Contamination to in-vitro diagnostic test may result in false positives.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioFire Diagnostics, LLC
Distributor
Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia.
Lot
Lot #s:0883425,0878825/DI: 00815381020192
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit. recalled?

Yes. FDA published recall Z-2067-2026 on May 13, 2026. Reported hazard: Contamination to in-vitro diagnostic test may result in false positives.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail